CD82 and cancer: Consistent with these observations, it has frequently been observed that expression of CD82 is inversely correlated with the invasive and metastatic potential of cancers of the breast, bladder, colon, cervix, gastrointestinal tract, skin, lung, prostate, pancreas, liver, and thyroid [10–13].